Subscribe to RSS

DOI: 10.1055/s-0045-1810028
Effect of Topical Intra-Auricular Lidocaine on Tinnitus: A Randomized Double-Blind Placebo-Controlled Study
Authors
Funding This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001.Clinical Trials Registration: Trial Registration Number NCT05711641

Abstract
Introduction
Tinnitus is a prevalent symptom and has no proven effective treatment. Clinical observations that some patients reported significantly improved tinnitus after topical ear drop administration of lidocaine motivated research on this drug.
Objective
Evaluate the action of topical intra-auricular 10% lidocaine in suppressing tinnitus compared to placebo.
Methods
This was a randomized, crossover, double-blind, placebo-controlled clinical trial. The variations of the visual analog scale (VAS), tinnitus loudness, and the minimum masking level (MML) after intra-auricular lidocaine 10% were compared with a placebo. The same variables were compared with some sample features.
Results
There was no statistically significant difference between the action of lidocaine and placebo in tinnitus variation measured by VAS (p = 0.361), tinnitus loudness (p = 0.850), and MML. (p = 0.213). The VAS variation was statistically lower in patients with any hearing loss (p = 0.005); the tinnitus loudness variation was higher in patients with tinnitus modulation (p = 0.049) and lower in patients with any hearing loss (p = 0.045). The MML variation was lower in patients with bruxism/TMD (p = 0.026).
Conclusion
In this study the action of lidocaine on the variation of tinnitus intensity was similar to placebo. We believe that the use of manipulated medication may have interfered in the outcome and that the large number of patients with positive response to placebo should be investigated in further studies.
Keywords
tinnitus - lidocaine - external acoustic meatus - local anesthetics - topical administration - clinical trialAuthors' Contributions
TVC: conceptualization, methodology, investigation, data curation and writing; RFB: conceptualization and supervision; JO: conceptualization; MSJ: investigation; NT: investigation; IJ: supervision; CLDM: investigation; RKT: conceptualization and supervision.
Data Availability Statement
Data supporting the results of this study are available upon a reasonable request from the corresponding author.
Publication History
Received: 16 October 2023
Accepted: 24 May 2025
Article published online:
16 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Tatiane Vacaro Campos, Ricardo Ferreira Bento, Jeanne Oticica, Maíra Said Jabour, Nathália Távora, Isabela Jardim, Cristiane Leite de Marchi, Robinson Koji Tsuji. Effect of Topical Intra-Auricular Lidocaine on Tinnitus: A Randomized Double-Blind Placebo-Controlled Study. Int Arch Otorhinolaryngol 2025; 29: s00451810028.
DOI: 10.1055/s-0045-1810028
-
References
- 1 Onishi ET, Coelho CCB, Oiticica J. et al. Tinnitus and sound intolerance: evidence and experience of a Brazilian group. Braz J Otorhinolaryngol 2018; 84 (02) 135-149
- 2 Jastreboff PJ, Sasaki CT. An animal model of tinnitus: a decade of development. Am J Otol 1994; 15 (01) 19-27
- 3 Dodson KM, Sismanis A. Intratympanic perfusion for the treatment of tinnitus. Otolaryngol Clin North Am 2004; 37 (05) 991-1000
- 4 Heller AJ. Classification and epidemiology of tinnitus. Otolaryngol Clin North Am 2003; 36 (02) 239-248
- 5 Shore SE, Wu C. Mechanisms of Noise-Induced Tinnitus: Insights from Cellular Studies. Neuron 2019; 103 (01) 8-20
- 6 Sanchez L. The Epidemiology of Tinnitus. Audiol Med 2004; 2: 8-17
- 7 Akdogan O, Ozcan I, Ozbek C, Dere H. Tinnitus after cochlear implantation. Auris Nasus Larynx 2009; 36 (02) 210-212
- 8 Levine RA. Somatic modulation appears to be a fundamental atribute of tinnitus. In: Hazell JPW. editor. Proceedings of the Six International Tinnitus Seminar. London: The Tinnitus and Hyperacusis Center; 1999: 193-197
- 9 Levine RA, Nam EC, Oron Y, Melcher JR. Evidence for a tinnitus subgroup responsive to somatosensory based treatment modalities. Prog Brain Res 2007; 166: 195-207
- 10 Sanchez TG, Rocha CB. Diagnosis and management of somatosensory tinnitus: review article. Clinics (Sao Paulo) 2011; 66 (06) 1089-1094
- 11 Shore SE, Roberts LE, Langguth B. Maladaptive plasticity in tinnitus–triggers, mechanisms and treatment. Nat Rev Neurol 2016; 12 (03) 150-160
- 12 Besteher B, Gaser C, Ivanšić D, Guntinas-Lichius O, Dobel C, Nenadić I. Chronic tinnitus and the limbic system: Reappraising brain structural effects of distress and affective symptoms. Neuroimage Clin 2019; 24: 101976
- 13 Vanneste S, De Ridder D. Brain areas controlling heart rate variability in tinnitus and tinnitus-related distress. PLoS One 2013; 8 (03) e59728
- 14 Simonetti P, Oiticica J. Tinnitus Neural Mechanisms and Structural Changes in the Brain: The Contribution of Neuroimaging Research. Int Arch Otorhinolaryngol 2015; 19 (03) 259-265
- 15 Langguth B, Schecklmann M, Lehner A. et al. Neuroimaging and neuromodulation: complementary approaches for identifying the neuronal correlates of tinnitus. Front Syst Neurosci 2012; 6: 15
- 16 Sanchez TG, Balbani AP, Bittar RS, Bento RF, Câmara J. Lidocaine test in patients with tinnitus: rationale of accomplishment and relation to the treatment with carbamazepine. Auris Nasus Larynx 1999; 26 (04) 411-417
- 17 Trellakis S, Lautermann J, Lehnerdt G. Lidocaine: neurobiological targets and effects on the auditory system. Prog Brain Res 2007; 166: 303-322
- 18 Beecham GB, Nessel TA, Goyal A. Lidocaine. [Updated 2022 Dec 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Jan-. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK539881/
- 19 Podoshin L, Fradis M, David YB. Treatment of tinnitus by intratympanic instillation of lignocaine (lidocaine) 2 per cent through ventilation tubes. J Laryngol Otol 1992; 106 (07) 603-606
- 20 Savastano M. Lidocaine intradermal injection–a new approach in tinnitus therapy: preliminary report. Adv Ther 2004; 21 (01) 13-20
- 21 O'Brien DC, Robinson AD, Wang N, Diaz R. Transdermal lidocaine as treatment for chronic subjective tinnitus: A pilot study. Am J Otolaryngol 2019; 40 (03) 413-417
- 22 Lloyd LL, Kaplan H. Audiometric interpretation: a manual on basic audiometry. Baltimore: University Park Press; 1978;94:16–17
- 23 Torp KD, Metheny E, Simon LV. Lidocaine Toxicity. [Updated 2022 Dec 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. Jan-. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK482479/
- 24 Kirkwood BR, Sterne JAC. Essential medical statistics. 2nd ed.. Massachusetts, USA: Blackwell Science; 2006: 502
- 25 McCullagh P, Nelder JA. Generalized linear models. 2nd ed.. New York: Chapman and Hall; 1989: 511
- 26 Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. Applied Linear Statistical Models. 4th ed.. Ilinois: Richard D. Irwing; 1996
- 27 Molnár A, Mavrogeni P, Tamás L, Maihoub S. Correlation Between Tinnitus Handicap and Depression and Anxiety Scores. Ear Nose Throat J 2022; 1455613221139211: 1455613221139211 Epub ahead of print
- 28 Otsuka K, Pulec JL, Suzuki M. Assessment of intravenous lidocaine for the treatment of subjective tinnitus. Ear Nose Throat J 2003; 82 (10) 781-784
- 29 Kallio H, Niskanen ML, Havia M, Neuvonen PJ, Rosenberg PH, Kentala E. I.V. ropivacaine compared with lidocaine for the treatment of tinnitus. Br J Anaesth 2008; 101 (02) 261-265
- 30 Brusis T, Loennecken I. Die Behandlung von Ohrgeräuschen mit der Iontophorese-Lokalanästhesie [Treatment of tinnitus with iontophoresis and local anesthesia]. Laryngol Rhinol Otol (Stuttg) 1985; 64 (07) 355-358
- 31 Laffrée JB, Vermeij P, Hulshof JH. The effect of iontophoresis of lignocaine in the treatment of tinnitus. Clin Otolaryngol Allied Sci 1989; 14 (05) 401-404
- 32 Xylestesin 2% sem vasoconstritor [bula de remédio]. Itapira: Cristália Produtos Químicos Ltda [acesso em 30 de maio de 2023]. Disponível em: https://www.cristalia.com.br/arquivos_medicamentos/280/Bula_Xylestesin_s.v_2_carpule_sol.inj_PS.pdf
- 33 Xylestesin 10%. Spray [bula de remédio]. Itapira: Cristália Produtos Químicos Ltda [acesso em 30 de maio de 2023]. Disponível em: https://www.cristalia.com.br/arquivos_medicamentos/293/Bula_Xylestesin_spray_10_PS.pdf
- 34 Fraga PV, Freitas G. Excipients commonly used in capsules and new perspectives. Revista Uningá. Dez 2015; 46: 46-50
- 35 Patel R, Barker J, ElShaer A. Pharmaceutical Excipients and Drug Metabolism: A Mini-Review. Int J Mol Sci 2020; 21 (21) 8224
- 36 Martins MRFM, Veiga F. Permeation enhancers in transdermal drug delivery systems: a new application of cyclodextrins. Rev Bras Cienc Farm 2002; 38 (01) 33-54 . Available from https://www.revistas.usp.br/rbcf/article/view/43766 . cited Oct 7, 2023 [Internet]
- 37 den Hartigh J, Hilders CG, Schoemaker RC, Hulshof JH, Cohen AF, Vermeij P. Tinnitus suppression by intravenous lidocaine in relation to its plasma concentration. Clin Pharmacol Ther 1993; 54 (04) 415-420
- 38 Bülow M, Best N, Brugger S, Derlien S, Loudovici-Krug D, Lemhöfer C. The effect of lidocaine iontophoresis for the treatment of tinnitus: a systematic review. Eur Arch Otorhinolaryngol 2023; 280 (02) 495-503
- 39 Vielsmeier V, Schlee W, Langguth B. et al. Lidocaine injections to the otic ganglion for the treatment of tinnitus-A pilot study. Prog Brain Res 2021; 260: 355-366
- 40 Lyttkens L, Larsson B, Wästerström SA. Local anaesthetics and tinnitus. Proposed peripheral mechanism of action of lidocaine. ORL J Otorhinolaryngol Relat Spec 1984; 46 (01) 17-23
- 41 Baguley DM, Jones S, Wilkins I, Axon PR, Moffat DA. The inhibitory effect of intravenous lidocaine infusion on tinnitus after translabyrinthine removal of vestibular schwannoma: a double-blind, placebo-controlled, crossover study. Otol Neurotol 2005; 26 (02) 169-176 Erratum in: Otol Neurotol. 2005 Nov;26(6):1264
- 42 Majumdar B, Mason SM, Gibbin KP. An electrocochleographic study of the effects of lignocaine on patients with tinnitus. Clin Otolaryngol Allied Sci 1983; 8 (03) 175-180
- 43 Coles RR, Thompson AC, O'Donoghue GM. Intra-tympanic injections in the treatment of tinnitus. Clin Otolaryngol Allied Sci 1992; 17 (03) 240-242